tirzepatide and semaglutide therapeutic modality vs Semaglutide: What You Need to Know Tirzepatide vs. Semaglutide for Weight

Some providers add a separate monthly membership of $74 to $149 on top of medication, and some raise the medication price as your dose climbs toward maintenance

According to the 2025 World Obesity Atlas, the number of obese people will increase by 115% (from 524 million to 1.13 billion) between 2010 and 2030

Severe gastrointestinal side effects leading to dehydration pose the greatest risk for kidney injury

Tirzepatide is a once-weekly injectable medication that combines GIP and GLP-1 receptor agonist activity to manage type 2 diabetes and support weight loss

Ongoing clinical and preclinical research continues to reveal benefits in liver and kidney disease, cardiovascular conditions, immune dysfunction, and more

Both Zepbound and Wegovy have depression listed as a potential side effect